Home › NDC Lookup › RxCUI directory › RxCUI 1247381

Amylase 78300 UNT / lipase 20880 UNT / protease 78300 UNT Oral Tablet [Viokace] — RxCUI 1247381

RxNorm drug concept · Semantic branded drug
RxCUI 1247381 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1247381
Official nameAmylase 78300 UNT / lipase 20880 UNT / protease 78300 UNT Oral Tablet [Viokace]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asViokase 20 Oral Tablet; Viokace 20,880 UNT / 78,300 UNT / 78,300 UNT Oral Tablet; Viokace 20 (amylase 78,300 UNT / lipase 20,880 UNT / protease 78,300 UNT) Oral Tablet; Viokase 20 (amylases 78,300 UNT / endopeptidases 78,300 UNT / lipase 20,880 UNT) Oral Tablet
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)985 prescriptions · 16 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Amylase 78300 UNT / lipase 20880 UNT / protease... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Amylase 78300 UNT / lipase 20880 UNT / protease 78300 UNT Oral Tablet [Viokace] RxCUI 1247381

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Amylase 743
    • Lipase 6406
    • Protease 8031
    • Amylase / lipase / protease 392491
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Viokace 1245781
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Amylase / lipase / protease Oral Tablet 402751
    • Amylase / lipase / protease Oral Product 1153486
    • Amylase / lipase / protease Pill 1153487
    • Amylase / lipase / protease Oral Tablet [Viokace] 1245962
    • Viokace Oral Product 1245784
    • Viokace Pill 1245785
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 18 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Amylase 78300 UNT / lipase 20880 UNT / protease 78300 UNT Oral Tablet SCD · 1247379
  • Amylase 78300 UNT SCDC · 1245964
  • Lipase 20880 UNT SCDC · 1858629
  • Protease 78300 UNT SCDC · 1245965
  • Amylase / lipase / protease Oral Tablet SCDF · 402751
  • Amylase / lipase / protease Oral Product SCDG · 1153486
  • Amylase / lipase / protease Pill SCDG · 1153487

Brand-Name Concepts

  • Amylase 78300 UNT / lipase 20880 UNT / protease 78300 UNT [Viokace] SBDC · 1858631
  • Amylase / lipase / protease Oral Tablet [Viokace] SBDF · 1245962
  • Viokace Oral Product SBDG · 1245784
  • Viokace Pill SBDG · 1245785
  • Viokace BN · 1245781

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 1247381 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
73562-0104-10 1 BOTTLE in 1 CARTON (73562-104-10) / 100 TABLET in 1 BOTTL... Viokace Aimmune Therapeutics, Inc. 2021-03-01
73562-0208-10 1 BOTTLE in 1 CARTON (73562-208-10) / 100 TABLET in 1 BOTTL... Viokace Aimmune Therapeutics, Inc. 2021-03-01
Observed labelers: Aimmune Therapeutics, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.